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ABSTRACT: Rh-N-heterocyclic carbene compounds [Rh(-Cl)(IPr)(2-olefin)]2 and RhCl(IPr)(py)(
2
-olefin) (IPr = 1,3-bis-
(2,6-diisopropylphenyl)imidazol-2-carbene, py = pyridine, olefin = cyclooctene or ethylene) are highly active catalysts for alkyne 
hydrothiolation under mild conditions. A regioselectivity switch from linear to 1-substituted vinyl sulfides was observed when 
mononuclear RhCl(IPr)(py)(2-olefin) catalysts were used instead of dinuclear precursors. A complex interplay between electronic 
and steric effects exerted by IPr, pyridine, and hydride ligands, accounts for the observed regioselectivity. Both IPr and pyridine 
ligands stabilize the formation of square-pyramidal thiolate-hydride active species, in which the encumbered and powerful electron 
donor IPr ligand directs the coordination of pyridine trans to it, consequently blocking the access of the incoming alkyne in this 
position. Simultaneously, the higher trans director hydride ligand paves the way to a cis thiolate-alkyne disposition, favoring the 
formation of 2,2-disubstituted metal-alkenyl species and subsequently the Markovnikov vinyl sulfides via alkenyl-hydride reductive 
elimination. DFT calculations support a plausible reaction pathway where the migratory insertion of the alkyne into the rhodium-
thiolate bond is the rate-determining step. 
 
INTRODUCTION 
Hydrothiolation of carbon-carbon multiple bonds is a direct 
and atom economical method for the formation of carbon-
sulfur bonds present in many biologically active compounds.
1 
Among them, vinyl sulfides, in addition to their interesting 
biological properties,
2
 are also useful synthetic intermediates 
in organic transformations,
3
 ranging from enol substitutes,
4
 
Diels-Alder,
5
 thio-Claisen,
6
 Michael acceptors,
7
 or olefin 
metathesis,
8
 among others.
9
 Several metal catalysts including 
Mo,
10
 Pd,
11
 Pt,
12 
Ni,
13
 Ru,
14
 Rh,
11c,15,16
 Ir,
16
 Cu,
17
 Au,
18
 Co,
19
 
In,
20
 Zr,
21
 An (Th, U)
22
, and Ln (La, Sm, Lu, Nd, Y)
22b
 are 
effective for hydrothiolation of unsaturated compounds, but 
the stereo- and regioselectivity control still remains an im-
portant challenge.  
In general, regioselectivity in the X-H addition across car-
bon-carbon triple bonds proceeding via X-H activation arises 
from a complex interplay between migratory insertion and 
reductive elimination steps (Scheme 1).
23,24
 Although electron-
ic and steric properties of the alkyne and the catalyst play an 
important role, the formation of linear metal-alkenyls via 1,2-
insertion (a,d) is generally preferred to that of branched iso-
mers via 2,1 insertion (b,c).
25,26
 Therefore, in a simplified 
overview, insertion into metal-hydride bond (a) gives rise to 
linear olefins (anti-Markovnikov or -type products) whereas 
insertion into metal-heteroatom bond (d) generates branched 
olefins (Markovnikov or -type products). Particularly for 
hydrothiolation, insertion into metal-hydride bonds is favored 
with regard to that into metal-thiolate, thus linear vinyl sul-
fides are preferably obtained.
11c,27
 Preparation of the branched 
vinyl sulfides, more valuables as synthetic intermediates,
3
 
could be accomplished in a controlled manner if a method for 
directing alkyne insertion into metal-thiolate bonds is devel-
oped. 
Scheme 1. Pathways for the alkyne migratory insertion 
into M-H or M-X bonds. 
 
A common strategy for the previously described selective 
preparation of 1-substituted vinyl sulfides catalyzed by a wide 
variety of metal complexes is to design active species bearing 
thiolate ligands and lacking of an hydride moiety (Scheme 
2).
11-13,15c,21,22
 In these catalytic systems the first step is thiol-
promoted protonolysis of an anionic ligand present in the 
precatalyst, or alternatively the formation of a bisthiolate com-
plex accompanied with the release of molecular hydrogen. 
However, in these cases it is difficult to inhibit the formation 
 of byproducts such as disulfide or bis(thio)alkenes. A priori, 
the formation of these unwanted products should be mini-
mized if a catalytic cycle involving initial S-H oxidative addi-
tion to the metal and successive alkyne insertion into metal-
thiolate bond, and alkenyl-hydride reductive elimination will 
be operative. Thus, the following question arises: How to 
favor alkyne M-S insertion in the presence of a hydride lig-
and? Perhaps the well-established high trans-director capacity 
of hydrides may be useful. Due to this property, the coordina-
tion of the incoming alkyne to the unsaturated hydride-thiolate 
catalytic intermediate may be channeled at the vacant position 
trans to the hydride ligand and concomitantly cis to the 
thiolate, thus favoring the formation of a 2,2-disubstituted 
alkenyl ligand and subsequently the branched vinyl sulfide. 
Particularly, Rh
I
 complexes are promising precursors to 
achieve this task as they are efficient catalysts for alkyne 
hydrothiolation.
11c,15,16
 Interestingly, their general tendency to 
favor linear vinyl sulfides can be reversed by ligand control, as 
was elegantly shown for Tp*Rh(PPh3)2 (Tp* = hydrotris(3,5-
dimethylpyrazolyl)borate) by Love’s group.
15b,d-f
 
Scheme 2. Strategies directed to the preparation of 
branched vinyl sulfides. 
 
In order to succeed with our proposal, a high control over 
coordination positions and potential isomerizations within the 
metal catalytic intermediates is essential.
28
 An N-heterocyclic 
carbene (NHC) ligand may fulfill the aimed requirements due 
to its special stereoelectronic properties.
29
 The high steric 
hindrance and powerful electron-donor capacity of bulky 
NHCs could govern the coordination positions of labile lig-
ands and substrates in the active species, thus determining the 
selectivity outcome. Indeed, NHC ligands have been revealed 
as suitable ligands not only for the stabilization of reactive 
intermediates, but also for the improvement of catalytic activi-
ty. In particular, substitution of typical ancillary ligands such 
as phosphanes by a more electron-donating NHC has extended 
the scope of many catalytic transformations.
30
 Interestingly, 
these type of ligands has also been applied to the design of 
Ni,
13c
 Cu,
17
 and Au
18
 alkyne hydrothiolation catalysts. Herein, 
we present a catalytic system for the selective hydrothiolation 
of alkynes based on a rhodium N-heterocyclic carbene frame-
work. A complex interplay between electronic and steric ef-
fects exerted by NHC, hydride and pyridine-type ligands ac-
counts for the regioselective formation of branched vinyl 
sulfides.  
RESULTS AND DISCUSSION  
Synthesis of rhodium-NHC catalysts. Dinuclear rhodium-
NHC monolefin complexes of type [Rh(-Cl)(NHC)(2-
olefin)]2
31
 are adequate precursors for a set of catalysts via 
either a controlled substitution of the 2-olefin or bridge-
cleaving reactions by different ligands. Specially, [Rh(-
Cl)(IPr)(2-coe)]2 (1) (coe = cyclooctene; IPr = 1,3-bis-(2,6-
diisopropylphenyl)imidazol-2-carbene), described by James’ 
group,
31b
 has been successfully applied in our laboratories as 
starting material for a variety of Rh
I
 and Rh
III
-NHC complex-
es.
32
 Interestingly, the two coe ligands can be exchanged by 
bubbling of ethylene through a toluene solution of 1 resulting 
in the formation of the dimer [Rh(-Cl)(IPr)(2-CH2=CH2)]2 
(2) (Scheme 3), which was isolated as a yellow solid in 92% 
yield. During the preparation of the manuscript an alternative 
method for the synthesis of 2 has been reported.
33
 The struc-
ture of 2 has been determined by X-ray analysis on crystals 
obtained from slow diffusion of n-hexane over toluene (see 
Supporting Information). This structure shows a very different 
unit cell dimension compared to that reported for 2·CH2Cl2.
33
 
Scheme 3. Synthesis of rhodium-NHC catalysts. 
 
Complex 2 showed a dynamic behavior as it was evidenced 
in a 
1
H VT-NMR study. That fact may be ascribed to two 
rotational processes involving both the 2-ethylene32b,34 and 
the carbene ligands (see Figure 2 for a similar behavior of 
4).
32b,35
 In the case of IPr, activation parameters were calculat-
ed by simulation of the coalescence of the two signals located 
at  2.93 and 2.60 ppm corresponding to the two types of CH-
isopropyl protons (C2 symmetry). The values obtained from 
the corresponding Eyring analysis were H

 = 13.9 ± 0.5 kcal 
mol
–1
 and S

 = –1.3 ± 1.1 cal K
–1
 mol
–1
 for the ethylene rota-
tion and H

 = 11.8 ± 0.4 kcal mol
–1
 and S

 = –1.5 ± 0.9 cal 
K
–1
 mol
–1
 for the IPr rotation.  
The chloro bridges in 1 and 2 were easily cleaved by 
nucleophilic pyridine ligands at room temperature, resulting in 
the formation of the mononuclear complexes RhCl(IPr)(L)(2-
coe) (L = pyridine (3), 2-picoline (5), 4-picoline (7), 2-
ethylpyridine (9)) and RhCl(IPr)(L)(2-ethylene) (L = pyridine 
(4), 2-picoline (6), 4-picoline (8), 2-ethylpyridine (10)) which 
were isolated as yellow solids in 77-86% yields.
36
 It is notice-
able that the alkene ligand was not replaced by pyridine even 
at 80 ºC in net pyridine overnight.
37
 Monocrystals of 3 suitable 
for X-ray analysis were obtained by slow diffusion of n-
hexane over a saturated solution of 3 in toluene (Figure 1). 
The complex has distorted square-planar geometry with pyri-
dine and chloro ligands disposed mutually trans to IPr and 
 coe, respectively [N(3)-Rh-C(10) 169.36(15)º; Cl-Rh-Ct 
166.02(14)º]. The rhodium-carbon separation [Rh-C(10) 
1.986(4) Å] compares well with previously reported rhodium-
NHC single bond distances.
29b
 The wingtips of IPr, the 2-
olefin and the pyridine adopt an out-of-plane disposition from 
the square-planar metal environment.
38
  
 
Figure 1. Molecular diagram of 3. Selected bond lengths 
(Å) and angles (º): Rh-Cl(1) 2.3886(13), Rh-N(3) 2.115(4), 
Rh-C(1) 2.149(4), Rh-C(2) 2.113(4), Rh-C(10) 1.986(4); Cl-
Rh-N(3) 84.43(10), Cl-Rh-C(10) 86.21(12), Cl-Rh-Ct 
166.02(14), N(3)-Rh-C(10) 169.36(15), N(3)-Rh-Ct 
94.42(17), C(10)-Rh-Ct 95.89(18). 
The 
1
H and 
13
C{
1
H} spectra of compounds 3-10 confirm the 
presence of 2-olefin, pyridine and IPr ligands. Similarly to 2, 
the IPr and ethylene ligands in 4 exhibited restricted rotation 
(Figure 2). The activation parameters obtained from the rate 
constants derived from a 
1
H VT-NMR study and the corre-
sponding Eyring analysis were H

 = 13.9 ± 0.5 kcal mol
–1
 
and S

 = –1.7 ± 1.2 cal K
–1
 mol
–1
 for the ethylene rotation 
and H

 = 14.1 ± 0.6 kcal mol
–1
 and S

 = –0.7 ± 1.4 cal K
–1
 
mol
–1
 for the IPr rotation. The values obtained for the rotation 
of ethylene in 4 are almost identical to that calculated for the 
dimer 2. In contrast, the barrier for the rotation of IPr around 
the Rh-C axis in 4 is 2.3 kcal mol
-1
 higher than in 2.  
 
 
Figure 2. Variable-temperature 
1
H-NMR spectra of 
RhCl(IPr)(pyridine)(2-ethylene) (4) in CD2Cl2 showing the 
coalescence of the CH-isopropyl and ethylene resonances: 
experimental (left) and calculated (right). 
The rotation barrier for the IPr ligand is also affected by the 
nature of the 2-olefin. Thus, substitution of ethylene by coe 
slightly hinders the rotational process as it is observed from 
the parameters calculated for 3 (H

 = 15.1 ± 0.7 kcal mol
–1
 
and S

 = –0.4 ± 1.9 cal K
–1
 mol
–1
). Similar values for IPr 
rotation were calculated for complex 6 bearing a 2-picoline 
ligand (H

 = 15.0 ± 0.7 kcal mol
–1
 and S

 = 
–
1.6 ± 1.6 cal 
K
–1
 mol
–1
). However, in this case, four CH-isopropyl signals 
were observed at low temperature ( 4.37, 4.09, 3.09, and 2.62 
ppm) which coalesced into two at 4.17 and 2.91 ppm. This 
fact can be explained by hindered rotation of 2-picoline, that 
breaks the plane of symmetry.  
The presence of a substituent in the 2-position of pyridine 
not only affects the rotation of the ligand but also the coordi-
nation to the metallic center. Thus, a temperature-dependent 
dynamic equilibrium between 6 and 2, as a result of the 
decoordination of 2-picoline, was observed between 293 and 
353 K (Figure 3). Thermodynamic parameters calculated from 
the Van’t Hoff representations (Ln Keq vs 1/T) were H
o
 = 
14.4 ± 0.5 kcal mol
–1
 and S
o
= 32.5 ± 1.3 cal K
–1
 mol
–1
. The 
process is endothermic whereas the slightly positive S
o
 
agrees well with an increase of internal disorder in the prod-
ucts due to decoordination of 2-picoline. It seems clear that an 
ortho-substituent on pyridine hinders the coordination of the 
ligand to the metallic center. In accordance to this, the 
disubstituted 2,6-dimethylpyridine was found unable to cleave 
the chloro bridges in 1-2. 
 
Figure 3. Variable-temperature 
1
H-NMR spectra in the or-
tho-piridine proton region for the dynamic equilibrium be-
tween 6 and 2. 
 Alkyne hydrothiolation catalytic studies. Wilkinson’s cat-
alyst RhCl(PPh3)3 has been previously revealed as an active 
catalyst for alkyne hydrothiolation.
11c,15e
 In view that the sub-
stitution of phosphanes by a more electron-donating NHC has 
extended the scope of many catalytic transformations,
30
 we 
have studied that effect in the present transformation (eq. 1). 
Addition of thiophenol to phenylacetylene was chosen as 
benchmark reaction (Table 1). Catalytic reactions using a 1:1 
thiol:alkyne ratio were monitored in an NMR tube in C6D6 at 
25 ºC with 2 mol % catalyst loading. A catalytic test with 
RhCl(PPh3)3 under our mild standard conditions showed high 
initial catalytic activity but also catalyst deactivation at about 
80 % conversion, displaying a high preference for the -E 
isomer (entry 1). In contrast, RhCl(IPr)(PPh3)2
31b
 showed full 
conversion to clean addition products after 3 h at room tem-
perature with a selectivity switch to 53/47 -E/ (entry 2). 
Although Wilkinson´s catalyst is initially more active than 
RhCl(IPr)(PPh3)2, the catalyst stability gained by the introduc-
tion of a IPr ligand compensates the loss of activity. Then, 
other phosphane-free Rh-NHC derivatives were tested as 
catalysts precursors. RhClIPr(cod)
39
 (cod = 1,5-
cyclooctadiene) reacts very slowly (18% after 24 h, entry 3) 
but the dinuclear 2-coe compound 1 surpassed the activity 
observed for RhCl(IPr)(PPh3)2 while maintaining clean full 
conversion and the preference for the anti-Markovnikov prod-
ucts (entry 4). The strong coordination of cod ligand in the 
former compared to the labile coe ligands in 1 may be deter-
minant for the very different catalytic activity.  
 
Table 1. Phenylacetylene Hydrothiolation with thiophenol 
at 25 ºC.
a 
Entry  Catalyst   t (h) conv. -E/   TOF1/2 (h
-1
)
b 
 1 RhCl(PPh3)3     0.5 80 92/8 300 
 2 RhCl(IPr)(PPh3)2     3 99 53/47   55 
 3 RhCl(IPr)(cod)   24 18 68/32    - 
 4 1     1 99 73/27 280 
 5 2     0.4 99 67/33 482 
 6 3     4 99   9/91   38 
 7 4     3 99 11/89   59 
 8 6     2.2 99 58/42 105 
 9 8     4 99 13/87   41 
 10   10     1.6 99 62/38 125 
 11 1 + 1 equiv py     4 99 10/90   38 
 12 2 + 1 equiv py     3 99 12/88   59 
 13 2 + 10 equiv py     7 99   6/94   22 
 14 2 + 10 equiv      6 99 37/63   30 
 15 none   24 37 8/92
c
/0   -- 
 16  pyridine
d
   24 13 9/91
c
/0   -- 
 17 1+ 10 equiv NEt3     7 99 59/41 28 
 18 1 + BHT     1 99 72/28 300 
a 0.5 mL of C6D6 with 2 mol % of catalyst. [subs] = 1 M.
b Determined 
at 50 % conversion. c Yield of -Z. d 20 mol % of pyridine. 
The exchange of coe ligands by ethylene in dimer 2 en-
hanced catalytic rate with similar preference to the linear iso-
mer (entry 5). Surprisingly, catalysts 3 and 4, bearing a pyri-
dine moiety, showed reverse regioselectivity although also a 
moderate decrease of catalytic activity (entries 6-7). The in-
situ addition of 1 equiv of pyridine to 1 and 2 gave similar 
results to 3 and 4, respectively (entries 11-12). It was observed 
that an increase of the amount of pyridine in the reaction me-
dia switches the equilibrium to the Markovnikov isomer up to 
94 % with the catalytic system 2 + 10 equiv of pyridine (entry 
13) (Figure 4). Only traces of disulfide were detected by GC-
MS analysis whereas -Z product was not observed in any of 
the catalytic runs carried out with 1-4. A blank test without 
metal catalysts showed after 24 h the formation of 37 % of 
linear vinyl sulfides of mainly Z configuration probably via 
radical process (entry 15).
40
 Addition of 2,6-di-tert-butyl-4-
methylphenol (BHT) to a sample catalyzed by 1 did not affect 
either the activity or the selectivity, thus excluding a mecha-
nism via radical species operating with our catalysts (entry 
18). Addition of pyridine to the blank test did not increase 
activity but rather slightly reduced it (entry 16). In order to 
discard that pyridine acts as a base, NEt3 was added to a sam-
ple catalyzed by 1. The ratio of the products was only slightly 
switched to the branched isomers (compare entries 4 vs 17). 
To further assess that the positive role of pyridine is played on 
coordination to active species, the catalytic activity of com-
plexes 6, 8, and 10 having 2-picoline, 4-picoline or 2-
ethylpyridine ligands, respectively, was studied (entries 8-10). 
Complex 8 gave similar results than 4 but catalysts 6 and 10, 
bearing 2-substituted pyridines, showed a behavior between 2 
and 4 both in terms of activity and selectivity. The hindered 
coordination of 2-picoline and 2-ethylpyridine, as showed in 
figure 3, can be the reason for this result. Indeed, displacement 
of the equilibrium to the coordinated species by addition of 10 
equiv of 2-picoline to 2 resulted in an increase of the 
regioselectivity to the -isomer (compare entries 8 vs 14). 
 
 Figure 4. Catalytic activity and regioselectivity outcome in 
hydrothiolation of phenylacetylene with thiophenol for cata-
lysts 2(•), 4(), 2 + 10 equiv pyridine (∆). 
Compounds 1-4 are versatile catalyst precursors. They pro-
mote the addition of thiophenol to different alkylic and aro-
matic alkynes (Table 2). The reaction rates for the alkylic ones 
were lower than those observed for phenylacetylene and thus 
the reactions were performed at 50 ºC. Strikingly, the “pyri-
dine effect” on the regioselectivity was maintained. The 
amount of the Markovnikov thioether product in the 
hydrothiolation of 1-hexyne was increased from 39/61 (2) to 
22/78 by using the pyridine complex 4 as catalyst (entries 1-2). 
Moreover, up to 96 % of branched isomer was obtained using 
2 + 10 equiv py as catalytic system with no significant isomer-
ization to internal vinyl thioether. In the case of the enyne 1-
ethynyl-1-cyclohexene a similar behavior was observed but it 
is noteworthy the complete chemoselectivity with the exclu-
sive addition of PhSH to the triple bond. More interestingly, 
the internal alkyne 3-hexyne gave exclusively the E-isomer 
(entry 7, eq 2) resulting from a syn addition of the thiol which, 
in addition to the absence of the -Z isomer thorough the 
different catalytic tests, point to a migratory insertion mecha-
nism for the alkyne hydrothiolation with these systems. The 
effect of modifying the electron density on the aromatic ring 
of phenylacetylene has been also studied. The introduction of 
an electron-donating group at the para position decreased both 
activity and selectivity (compare entry 8, table 2 vs entry 11, 
table 1) whereas the presence of an electron-withdrawing 
substituent resulted in higher TOF and regioselectivity (entry 
9). A propargyl ether was also effective with similar isomeric 
distribution (entry 10). 
Table 2. Alkyne Hydrothiolation with thiophenol.
a
 
Entry  Alkyne Cat   T(ºC)   t (h)  conv. -E/  TOF1/2(h
-1
) 
 1  2 50   7 99 39/61 25 
 2  4 50   9.4 99 22/78 19 
 3  2 + 50 24 95 4/96   1 
 10 equiv py  
 4  2 50   3.5 99 62/38 47 
 5  4 50   5.5 99 49/51 30 
 6  2 + 50 13 92 34/66 16 
 10 equiv py 
 7  2 50 20 95    --
b
   1 
 8  2 + 25 18 99 10/90   7 
 10 equiv py 
 9  2 + 25   4 99 3/97 45 
 10 equiv py 
 10  2 + 50 18 99 10/90   7 
 10 equiv py 
a 0.5 mL of C6D6 with 2 mol % of catalyst. [subs] = 1 M.
b exclusive 
formation of (E)-3-phenylsulfanyl-3-hexene. 
 
The scope of the catalysts was investigated by using differ-
ent thiols (Table 3). Again, the regioselectivity can be tuned by 
pyridine addition. Benzyl hydrosulfide, PhCH2SH, reacted 
much faster than PhSH (entries 1-4). In fact, full conversion 
was attained with 2 after the first recorded 
1
H NMR spectrum 
(≈3 min) with our standard conditions. A reduction of the 
amount of catalyst 2 to 0.5 mol % gave the same result, with a 
calculated TOF of 4000 h
–1
. As it was previously shown for 
PhSH, catalyst 4 and the catalytic system 2 + 10 equiv py were 
less active but much more selective to the -isomer. A doubly 
protected N-tert-butoxycarbonyl (Boc) and methylester cyste-
ine was also transformed into the vinyl thioether with high 
activity under mild conditions (TOF1/2 of 250-580 h
–1
) (entries 
5-7). Thus, our catalysts are compatible with other functional 
groups giving good selectivities to the  vinyl sulfide isomer. 
Indeed, functionalization of cysteine is an important goal for 
the synthesis of biologically active derivatives. Interestingly, 
1,6-hexanedithiol undergoes a double addition process with 
good selectivity to the , product (88%, entry 8, eq 3).  
Table 3. Hydrothiolation of phenylacetylene with different 
thiols at 25 ºC.
a 
Entry  Thiol Catalyst t (h) conv. -E/  TOF1/2 (h
-1
) 
 1  2 0.05 99 33/67   -- 
 2  2
c
 0.05 99 31/69 4000
b
 
 3  4 0.08 99 26/74   625
b
 
 4  2 + 0.4 99 7/93   510 
 10 equiv py  
 5  2 0.25 99 37/63   580 
 6  4 0.5 99 23/77   420 
 7  2 + 1.2 99 10/90   250 
 10 equiv py 
 8  2 + 0.7 99 11/88
d
 ..390 
 10 equiv py 
a 0.5 mL of C6D6 with 2 mol % of catalyst. [subs] = 1 M. 
b Measured at 
full conversion.c 0.5 mol % of 2.d ratio between -E, and ,. 
 
Mechanistic proposal. A number of possible mechanisms 
for alkyne hydrothiolation have been postulated. The trans-
addition product, -Z vinyl sulfides, are mainly formed in the 
 absence of catalyst via a radical pathway.
40
 In our catalytic 
system the inversion of regioselectivity promoted by pyridine 
addition do not proceed by radical intermediates as the addi-
tion of a radical trap (BHT) did not influence either the activi-
ty or the selectivity. On the other hand, the external attack of 
the thiol on a coordinated alkyne is unlikely as the exclusive 
formation of the syn-addition -E vinyl sulfide product was 
observed in the hydrothiolation of internal alkynes. In fact, we 
fail to detect any well-defined compound from the addition of 
a stoichimetric amount of phenylacetylene to 1 or 3. Thus, the 
above results suggest a classical S-H oxidative addition and 
successive alkyne insertion and reductive elimination process-
es as the plausible mechanism operating with our catalysts 
(Scheme 1). 
In order to shed light on the effect of pyridine coordination 
on the regioselectivity outcome, several stoichiometric NMR 
experiments were carried out. Treatment of 1 with thiophenol 
gave rise to an unidentified mixture of rhodium-hydrides, 
probably originated from oxidative addition of PhSH.
41
 In fact, 
the formation of several mononuclear or dinuclear thiolate- or 
chloro-bridged complexes can be envisaged.
42
 However, when 
the pyridine complex 3 was treated with PhSH, a doublet at –
26.55 ppm with a JRh-H = 48.5 Hz appeared as the main hy-
dride species, along with the presence of free coe. The upfield 
shift and the high coupling constant of this resonance suggest 
a square-pyramidal structure with the hydride occupying the 
apical position.
32a,43
 Unfortunately, complex 
RhClH(SPh)(IPr)(py) (11) could not be isolated. Addition of 1 
equiv of phenylacetylene at –20 ºC to an NMR sample of 11 
generated in-situ led to smoothly formation of the organic 
product phenyl(1-phenylvinyl)sulfane, resulting from the 
Markovnikov addition of PhSH to the alkyne, and a mixture of 
unidentified rhodium species with concomitant disappearance 
of the hydride signal. The fact that alkenyl intermediates could 
not be detected points to the migratory insertion as the rate-
determining step. In accordance to this, alkyl thiols react faster 
than thiophenol. Although the more acidic thiophenol facili-
tates the oxidative addition step, the more basic sulfur atom of 
alkyl thiolate ligands should favor the migratory insertion. 
Indeed, the observation that an electron-withdrawing group at 
para position of the aromatic ring of phenylacetylene increas-
es the activity is in accordance with this proposal. The inser-
tion of alkyne into the Rh-S bond should be facilitated by a 
decrease in the electronic density on the C-C triple bond. 
It seems likely that the oxidative addition of the thiophenol 
to 3 generates an unsaturated pentacoordinated complex 11, 
via decoordination of the olefin on the electron-poor Rh
III
 
intermediate, with the pyridine occupying the less congested 
trans position regarding to the high sterically demanding IPr. 
Indeed, DFT calculations on the stability of different unsatu-
rated square-pyramidal isomers with pyridine (11a), chloride 
(11b), and thiolate (11c) located trans to IPr, showed that 11a 
is 13.5 and 14.3 kcal mol
–1
 more stable than 11b and 11c, 
respectively (Figure 5). The trigonal bypiramidal structure for 
these species was not found as minima in any case. In addi-
tion, the bulky IPr ligand makes difficult the coordination of 
the amine ligands in the equatorial position. In fact, several 
studies on saturated complexes having two pyridine ligands 
have shown that the pyridine ligand cis to IPr is more labile or 
even decoordinates on increasing the steric demand on the 
NHC ligand.
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Figure 5. DFT computed energies for the pentacoordinated 
square-pyramidal structures of 11. 
In contrast to the behavior observed for 3, the treatment of 1 
with 1 equiv of PhSH and 3 equiv of pyridine per metal atom 
in tol-d8 gave rise to a mixture of two hydride species in dy-
namic equilibrium: the unsaturated complex 11 and the satu-
rated RhClH(SPh)(IPr)(py)2 (11-py), which exhibited a dou-
blet at  –16.95 ppm with JRh-H = 15.6 Hz, in 1:2.5 ratio at 20 
ºC. The new saturated octahedral 11-py results from the coor-
dination of pyridine ligand in 11. Similar downfield shift and 
reduction of the JRh-H coupling constant has been previously 
observed in related rhodium complexes by coordination of 
pyridine to the vacant site of the square-pyramidal hydride 
precursors.
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A 
1
H VT-NMR study confirmed the dynamic equilibrium 
between 11 and 11-py (Figure 6). As can be seen in the right 
part of the figure, that shows the hydride region of the spectra, 
on lowering the temperature from 303 to 243 K the intensity 
of the hydride signal corresponding to 11 diminishes and 
shifts to lower field approaching to that of 11-py which slight-
ly broadens. More informative is the left part of the figure. 
The ortho-protons of the pyridine ligand of 11 (●) integrates 
by 2 related to the hydride located at upfield shift, which sug-
gests the free rotation of the pyridine ligand that makes both 
ortho-protons equivalents. This resonance does not change 
much with temperature. In contrast, the 
1
H NMR spectrum at 
243 K of 11-py displays three signals for the four ortho-
pyridine protons. The resonance at 9.06 ppm integrates 2:1 
with respect to the hydride signal at –16.27 ppm and it is 
assigned to the both ortho-pyridine protons of the ligand trans 
to IPr (‡). In contrast, the signals corresponding to the pyridine 
ligand cis to IPr in 11-py (□) split into two resonances at 9.58 
and 9.31 ppm, probably by hindered rotation of the pyridine 
due the proximity of bulky IPr. At higher temperature these 
resonances coalesce to a single resonance over 263 K and 
exchange with that corresponding to free pyridine (#). Interest-
ingly, the hydride signal for 11 shifts to lowfield at low tem-
perature but remains unchanged over 303 K. This observation 
suggests that 11 is likely involved in another equilibrium, 
probably a dimerization process, resulting in the saturation of 
the vacant site.
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Coordination of pyridine cis to IPr is not exclusively deter-
mined by the sterical pressure of the carbene ligand. Treatment 
of 1 with 1 equiv of benzylthiol and 3 equiv of pyridine per 
metal atom resulted in the exclusive formation of a pyridine-
saturated hydride complex RhClH(SCH2Ph)(IPr)(py)2 (12-py) 
(Figure 7). The 
1
H VT-NMR spectra of 12-py are very similar 
to that of 11-py. In particular, the hydride ligand was observed 
as a doublet at  –17.31 ppm with JRh-H = 15.0 Hz at 25 ºC. In 
 the ortho-pyridine region a doublet at 9.28 ppm (JH-H = 5.2 
Hz) corresponds to the pyridine ligand trans to IPr whereas the 
cis pyridine ligand splits into two signals at 9.45 and 9.19 ppm 
at 243 K. However, there is no equilibrium between 12-py and 
the potential unsaturated compound 12. Benzylthiolate is more 
flexible than phenylthiolate and thus complex 12-py can ac-
commodate a second pyridine ligand more easily than 11-py. 
The steric influence of the ancillary ligands also affects the 
potential coordination of a N-donor ligand trans to the hydride 
ligand, as observed in the in-situ formation of the 2-
ethylpyridine complex RhClH(SCH2Ph)(IPr)(Et-py) (13). The 
increase of the steric bulk exerted by the 2-ethylpyridine pre-
vents the formation of the saturated complex 13-py and thus, 
the clean formation of square-pyramidal 13 was observed (–
26.93 ppm, JRh-H = 47.0 Hz). 
 
Figure 6. Stacked plot of variable-temperature 
1
H NMR 
spectra in tol-d8 in the ortho-pyridine (left) and hydride (right) 
regions of the equilibrium between 11 and 11-Py 
 
Figure 7. 
1
H NMR spectra in tol-d8 at 223 K for 12-py (oc-
tahedral) and 13 (square-pyramidal). 
The unsaturated square-pyramidal species a similar to 11, is 
the key for the explanation of the observed regioselectivity 
outcome (Scheme 4). The high trans influence of the hydride 
ligand determines the stereochemistry of the complex and 
directs the coordination of the incoming ligand (alkyne or 
pyridine) trans to it (b). Therefore the alkyne is now located in 
cis disposition regarding to the thiolate ligand thus favorig 
migratory insertion between both groups to generate a 2,2-
disubstituted alkenyl ligand (c).
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 Reductive elimination within 
c generates a branched vinyl sulfide. The influence of the 
pyridine excess on the activity and regioselectivity should be 
related with an increase of the concentration of a in the 
reaction media. Although the formation of the species such as 
11-py may retard the alkyne coordination, resulting in an 
inferior catalytic activity as it was observed for the catalytic 
system 2 + 10 equiv pyridine, it could also help to prevent 
both the decoordination of pyridine and the isomerization of a 
thus increasing the selectivity. In fact, decoordination of 
pyridine give rise to an hypothetical square–pyramidal 
pentacoordinated species d with the alkyne trans to IPr and cis 
to both hydride and thiolate ligands where insertion into Rh-H 
or Rh-S bonds is now possible therefore accounting for an 
unselective catalytic outcome. Catalytic pathway via d is 
probably operating with the dinuclear catalyst precursors 1 and 
2, or the phosphane catalyst RhCl(IPr)(PPh3)2, which exhibit 
good activity but moderate regioselectivity. In the case of 2-
subtituted pyridine complexes 5, 6, 9, and 10 the steric 
repulsion between the substituent and the incoming alkyne 
reduces the ability for these catalyst to generate b-type 
intermediates and also favors pyridine decoordination, as 
shown in figure 3, driven the catalytic reaction through type d 
intermediates.  
Scheme 4. Proposed catalytic cycle for the regioselective 
alkyne hydrothiolation leading to branched vinyl sulfides. 
 
Consequently, a complex interplay between stereoelectronic 
properties of IPr, pyridine and hydride ligands accounts for the 
good-to-excellent regioselectivity achieved with these catalytic 
systems. It is likely that IPr and hydride direct pyridine 
coordination to the more favorable coordination site, that 
located trans to IPr. Alkyne is now forced to coordinate trans 
to hydride and so cis to thiolate favoring Markovnikov 
selectivity. The absence of pyridine allows the alkyne to 
coordinate in the preferred site trans to IPr position, and thus 
subsequent unselective migratory insertion takes place. This 
 catalytic system is an example where pyridine plays an 
important role as additive in a transition-metal mediated 
catalytic transformation.
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 The “pyridine effect” in this system 
has been rationalized with a molecular basis and it is further 
supported by theoretical calculations. 
Theoretical calculations on the reaction mechanism. To 
gain more insight about the feasibility of our proposed mecha-
nism, theoretical calculations on the catalytic cycle were per-
formed for phenylacetylene and thiophenol (DFT, B3LYP, 
kcal mol
-1
, Figure 8). As far as we know, theoretical studies 
dealing with alkyne hydrothiolation or insertion of an alkyne 
into metal-thiolate bonds are scarce.
13d,48
 Calculations of the 
involved organometallic intermediates were performed with-
out any simplifying approximation in order to increase accura-
cy of the results. The starting point is the square-pyramidal 
thiolate-hydride species 11a (Figure 5) and phenylacetylene. 
In 11a only migratory insertion of the alkyne into rhodium-
thiolate is possible but discrimination between migration into 
 or  carbon atoms of the alkyne determines the configura-
tion of the final product. Thus, both pathways for the insertion 
of thiol were calculated. The red line shows the 1,2-insertion 
or Markovnikov addition pathway (a) whereas the blue line 
corresponds to the 2,1-insertion or anti-Markovnikov route (b) 
(Figure 8). Complete energy profile shows that the reaction is 
kinetically determined by the migratory insertion step as the 
highest hurdle. In accordance with the experimental results, 
the formation of branched vinyl sulfides obtained via 
Markovnikov pathway is favored. The possibility of migratory 
insertion of the alkyne into the rhodium-hydride bond has 
been also calculated. In agreement with our mechanistic pro-
posal the transition states for both insertion types are higher in 
energy than TSIa (25.9 and 27.7 kcal mol
–1
, see Supporting 
Information for details). 
 
Figure 8. Computed potential-energy profile for the alkyne 
migratory insertion and reductive elimination for the for-
mation of vinyl sulfide. 
It has been determined that the coordination of the alkyne to 
11a is hindered by sterical means, thus a stationary point for 
the saturated species similar to b (Scheme 4) was not found 
for either alkyne orientation. However, we were able to locate 
the transition states corresponding to C-S and Rh-C coupling 
for both pathways (TSIa and TSIb). An affordable value of 
24.0 kcal mol
–1
 was computed for 1,2 insertion TSIa which is 
4.3 kcal mol
–1
 lower in energy than TSIb. Either transition 
state displays a roughly metalacyclobutene structure including 
the metal, sulfur and the two carbon atoms of the former al-
kyne (Figure 9). Rhodium-thiolate and C-C bonds slightly 
elongate from 2.355 Å in 11a and 1.210 Å in phenylacetylene 
to 2.414 Å (Rh-S) and 1.276 Å (C-C) in TSIa and 2.399 Å 
(Rh-S) and 1.260 Å (C-C) in TSIb. 
Intermediates Ia and Ib bearing a thioalkenyl ligand, similar 
to proposed species c, were found to be –10.2 and –6.1 kcal 
mol
–1
 more stable than the starting point. The new Rh-C bond 
formed agrees with typical simple bond distances, 2.007 Å in 
Ia and 2.010 Å in Ib. In the reductive elimination step, two 
new transition states were located at 8.5 kcal mol
-1
 (TSIIb) 
and –2.0 kcal mol
–1
 (TSIIa) being again the anti-Markovnikov 
pathway unfavorable. The final point corresponding to the 
unsaturated species RhCl(IPr) II and the respective coupled 
organic products is slightly more favorable for the formation 
of linear vinyl sulfides (–3.8 vs –0.1 kcal mol
–1
) although both 
pathways are thermodynamically less energetic that the start-
ing point.  
 
  
Figure 9. Optimized structures for the intermediates and transition states for migratory insertion and reductive elimination steps 
including selected distances (Å) and angles (deg). 
 
CONCLUSION 
Herein we have presented highly active Rh-NHC catalysts 
for alkyne hydrothiolation under mild conditions. Pyridine-
type ligands easily cleave the chloro-bridges in dinuclear 
derivatives [Rh(-Cl)(IPr)(2-olefin)]2 to afford stable mono-
nuclear complexes RhCl(IPr)(L)(2-coe). The presence of a 
powerful electron-donor bulky IPr ligand prevents deactiva-
tion of active species thus increasing catalytic activity com-
pared to RhCl(PPh3)3. It has been found that dinuclear com-
plexes are more active than their related pyridine mononuclear 
complexes. However, a reversion in the regioselectivity from 
-E to  was observed with mononuclear catalysts compared 
to dinuclear precursors.  
It has been also determined that the mechanism proceeds via 
oxidative-addition of the S-H bond to Rh
I
 intermediates and 
successive alkyne migratory insertion and reductive elimina-
tion steps. The regioselectivity of the catalytic outcome is 
determined by the alkyne migratory insertion into the Rh-S 
bond. The interplay of electronic and steric effects exerted by 
IPr, pyridine and hydride ligands accounts for the 
regioselective formation of branched vinyl sulfides as a con-
sequence of the 1,2-insertion into the rhodium-thiolate bond. 
The encumbered and powerful electron donor NHC ligand 
directs the coordination of the pyridine trans to it, consequent-
ly blocking the coordination of the alkyne in this position. 
Simultaneously, the trans influence of the hydride paves the 
way to a cis thiolate-alkyne disposition that gives rise to the 
branched vinyl sulfide regioisomer. This mechanistic proposal 
is supported by DFT quantum-mechanical calculations. The 
rate-determining step is the alkyne migratory insertion leading 
to the C-S bond formation. The energy difference of 4.3 kcal 
mol
–1
 favoring the 1,2 over the 2,1-migratory insertion fully 
account for the observed regioselectivity. 
The findings reported herein could be useful for the rational 
molecular design of new catalysts with improved 
regioselectivity in related addition processes such as 
hydroalkoxylation, hydrophosphination, hydroamination or 
hidroacylation among others. With the aim to improve activity 
and selectivity, catalysts design by modification of both NHC 
and ancillary ligands is currently investigated in our laborato-
ries.  
EXPERIMENTAL SECTION 
General considerations. All reactions were carried out with 
rigorous exclusion of air using Schlenk-tube techniques. Or-
ganic solvents were dried by standard procedures and distilled 
under argon prior to use or obtained oxygen- and water-free 
from a Solvent Purification System (Innovative Technologies). 
The starting material [Rh(-Cl)(IPr)(coe)]2 (1) was prepared as 
previously described in the literature.
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1
H, 
13
C{
1
H}, and 
19
F 
NMR spectra were recorded on either a Varian Gemini 2000, a 
Bruker ARX 300 MHz a Bruker Avance 400 MHz or a Bruker 
Avance 500 MHz instrument. Chemical shifts (expressed in 
parts per million) are referenced to residual solvent peaks (
1
H, 
13
C{
1
H}) or external CFCl3 (
19
F). Coupling constants, J, are 
given in hertz. Spectral assignments were achieved by combi-
nation of 
1
H-
1
H COSY, 
13
C APT and 
1
H-
13
C HSQC/HMBC 
experiments. C, H, and N analyses were carried out in a Per-
kin-Elmer 2400 CHNS/O analyzer. GC-MS analysis were run 
on an Agilent 5973 mass selective detector interfaced to an 
 Agilent 6890 series gas chromatograph system, using a HP-
5MS 5% phenyl methyl siloxane column (30 m x 250 m with 
a 0.25 m film thickness). 
Preparation of [Rh(-Cl)(IPr)(2-CH2=CH2)]2 (2). A yel-
low solution of 1 (300 mg, 0.236 mmol) in 10 mL of toluene 
at room temperature was bubbled with ethylene for 15 min. 
Then, the solvent was evaporated to dryness and subsequent 
addition of hexane caused the precipitation of a yellow solid 
which was washed with hexane (3 x 4 mL) and dried in vacuo. 
Yield: 240 mg (92%). Anal. Calcd. for C58H80N4Cl2Rh2: C, 
62.76; H, 7.26; N, 5.05. Found: C, 62.45; H, 7.15; N, 4.94. 
1
H 
NMR (300 MHz, tol-d8, 233 K): δ 7.3-7.1 (m, 12H, HPh-IPr), 
6.19 (s, 4H, =CHN), 3.27 and 2.90 (both sept, JH-H = 6.6, 8H, 
CHMeIPr), 2.84 and 2.27 (both d, JH-H = 12.6, 8H, CH2=CH2), 
1.62, 1.47, 1.00, and 0.96 (all d, JH-H = 6.6, 48H, CHMeIPr). 
13
C{
1
H}-APT NMR plus HSQC and HMBC (75.4 MHz, tol-
d8, 233 K):  179.7 (d, JC-Rh= 62.3, Rh-CIPr), 146.2 and 145.2 
(both s, Cq), 137.0 (s, CqN), 129.1 and 123.6 (s, CHPh-IPr), 
123.7 (s, =CHN), 43.4 (d, JC-Rh = 16.7, CH2=CH2), 28.5(s, 
CHMeIPr), 25.8 and 23.3 (both s, CHMeIPr). 
Preparation of RhCl(IPr)(2-coe)(py) (3). A yellow solu-
tion of 1 (300 mg, 0.236 mmol) in 10 mL of toluene was treat-
ed with pyridine (200l, 2.47 mmol) and stirred at room tem-
perature for 15 min. Then, the solvent was evaporated to dry-
ness and subsequent addition of hexane caused the precipita-
tion of a yellow solid which was washed with hexane (3 x 4 
mL) and dried in vacuo. Yield: 280 mg (83%). Anal. Calcd. 
for C40H55N3ClRh: C, 67.07; H, 7.73; N, 5.87. Found: C, 
66.83; H, 7.55; N, 6.02. 
1
H NMR (300 MHz, C6D6, 298 K): δ 
8.40 (d, JH-H = 4.3, 2H, H2-Py), 7.4-7.2 (m, 6H, HPh-IPr), 6.64 (s, 
2H, =CHN), 6.55 (t, JH-H = 5.4, 1H, H4-Py), 6.20 (dd, JH-H = 
5.4, JH-H = 4.3, 2H, H3-Py), 4.52 and 2.61 (both sept, JH-H = 6.4, 
4H, CHMeIPr), 3.12 (m, 2H, CH=CHcoe), 1.81, 1.47, 1.15, and 
1.02 (all d, JH-H = 6.4, 24H, CHMeIPr), 1.8-0.8 (br, 12H, CH2-
coe). 
13
C{
1
H}-APT NMR plus HSQC and HMBC (75.6 MHz, 
C6D6, 253 K):  183.3 (d, JC-Rh= 54.0, Rh-CIPr), 153.9 (s, C2-
Py), 149.3 and 146.6 (both s, Cq), 138.3 (s, CqN), 135.1 (s, C4-
Py), 129.7, 128.9, 125.5, and 123.1 (all s, CHPh-IPr), 124.8 (s, 
=CHN), 122.9 (s, C3-Py), 56.1 (d, JC-Rh = 16.4, CH=CHcoe), 
30.6, 30.4, and 27.3 (all s, CH2-coe), 29.5 and 29.4 (both s, 
CHMeIPr), 27.2, 27.1, 24.6, and 23.1 (all s, CHMeIPr). 
Preparation of RhCl(IPr)(2-CH2=CH2)(py) (4). The 
complex was prepared as described for 3 starting for 2 (300 
mg, 0.270 mmol) and pyridine (220l, 2.72 mmol). Yield: 290 
mg (85%). Anal. Calcd. for C34H45N3ClRh: C, 64.40; H, 7.15; 
N, 6.63. Found: C, 64.22; H, 7.02; N, 6.45. 
1
H NMR (500 
MHz, tol-d8, 253 K): δ 8.32 (d, JH-H = 4.5, 2H, H2-Py), 7.3-7.1 
(m, 6H, HPh-IPr), 6.54 (s, 2H, =CHN), 6.46 (t, JH-H = 5.5, 1H, 
H4-Py), 6.08 (dd, JH-H = 5.5, JH-H = 4.5 2H, H3-Py), 4.09 and 3.08 
(both sept, JH-H = 6.5, 4H, CHMeIPr), 2.52 and 2.03 (both d, JH-
H = 11.5, 4H, CH2=CH2), 1.91, 1.57, 1.23, and 1.13 (all d, JH-H 
= 6.5, 24H, CHMeIPr). 
13
C{
1
H}-APT NMR plus HSQC and 
HMBC (125.6 MHz, tol-d8, 253 K):  183.3 (d, JC-Rh= 54.5, 
Rh-CIPr), 151.5 (s, C2-Py), 148.1 and 145.4 (both s, Cq), 137.4 
(s, CqN), 134.5 (s, C4-Py), 129.1, 128.4, 124.2, and 122.7 (all s, 
CHPh-IPr), 123.7 (s, =CHN), 122.5 (s, C3-Py), 41.6 (d, JC-Rh = 
15.4, CH2=CH2), 28.9 and 28.7 (both s, CHMeIPr), 26.3, 26.1, 
23.9, and 22.9 (all s, CHMeIPr). 
Preparation of RhCl(IPr)(2-coe)(2-picoline) (5). The 
complex was prepared as described for 3 starting for 1 (300 
mg, 0.236 mmol) and 2-picoline (230l, 2.329 mmol). Yield: 
275 mg (80%). Anal. Calcd. for C41H57N3ClRh: C, 67.43; H, 
7.87; N, 5.75. Found: C, 67.74; H, 7.91; N, 5.68. 
1
H NMR 
(300 MHz, C6D6, 293 K): δ 8.43 (d, JH-H = 5.2, 1H, H6-Py), 
7.49-7.11 (m, 6H, HPh-IPr), 6.71 and 6.61 (both d, JH-H = 1.4, 
2H, =CHN), 6.57 (dd, JH-H = 7.9, JH-H = 7.6, 1H, H4-Py), 6.34 
(d, JH-H = 7.6, 1H, H3-Py), 6.21 (dd, JH-H = 7.9, JH-H = 5.2, 1H, 
H5-Py), 4.96, 4.16, 2.83 and 2.20 (all sept, JH-H = 6.4, 4H, 
CHMeIPr), 3.07 (m, 2H, CH=CHcoe), 2.75 (s, 3H, HCH3-Py), 
1.97, 1.65, 1.49, 1.33, 1.22, 1.11, 1.07 and 0.94 (all d, JH-H = 
6.4, 24H, CHMeIPr), 1.8-0.8 (br, 12H, CH2-coe). 
13
C{
1
H}-APT 
NMR plus HSQC and HMBC (75.6 MHz, C6D6, 293 K):  
185.7 (d, JC-Rh= 53.5, Rh-CIPr), 162.1 (s, C2-Py), 153.0 (s, C6-Py), 
149.7, 149.4, 146.9 and 146.7 (all s, Cq), 138.5, 138.0 (both, 
CqN), 135.0 (s, C4-Py), 130.1, 129.9, 126.0, 125.5, and 123.4, 
122.9 (all s, CHPh-IPr), 125.2 and 124.9 (both s, =CHN), 124.6 
(s, C3-Py), 119.9 (s, C5-Py), 58.3, 52.5 (both d, JC-Rh = 16.3, 
CH=CHcoe), 31.3, 30.0, 29.4, 29.3, 27.4, and 27.2 (all s, CH2-
coe), 29.9, 29.7, 29.2 and 29.0 (all s, CHMeIPr), 27.9, 27.3, 
27.1, 26.7, 25.0, 24.1, 23.5, and 22.5 (all s, CHMeIPr), 26.9 (s, 
CCH3-Py). 
Preparation of RhCl(IPr)(2-CH2=CH2)(2-picoline) (6). 
The complex was prepared as described for 3 starting for 2 
(300 mg, 0.270 mmol) and 2-picoline (270l, 2.734 mmol). 
Yield: 270 mg (77%). Anal. Calcd. for C35H47N3ClRh: C, 
64.86; H, 7.31; N, 6.48. Found: C, 65.01; H, 7.45; N, 6.37. 
1
H 
NMR (500 MHz, tol-d8, 253 K): δ 8.21 (d, JH-H = 5.3, 1H, H6-
Py), 7.37-7.09 (m, 6H, HPh-IPr), 6.59 and 6.49 (both d, JH-H = 
1.6, 2H, =CHN), 6.47 (dd, JH-H = 8.0, JH-H = 7.7, 1H, H4-py), 
6.14 (d, JH-H = 7.7, 1H, H3-Py), 5.93 (dd, JH-H = 8.0, JH-H = 5.3, 
1H, H5-Py), 4.32, 4.05, 3.05 and 2.59 (all sept, JH-H = 6.7, 4H, 
CHMeIPr), 2.58 (s, 3H, HCH3-Py), 2.56, 2.35, 2.04 and 1.64 (all 
dd, JH-H = 11.7, JH-H = 8.8, 4H, CH2=CH2), 1.94, 1.70, 1.49, 
1.40, 1.21, 1.13, 1.10 and 1.02 (all d, JH-H = 6.7, 24H, 
CHMeIPr). 
13
C{
1
H}-APT NMR plus HSQC and HMBC (125.6 
MHz, tol-d8, 293 K):  184.9 (d, JC-Rh= 53.8, Rh-CIPr), 160.9 
(s, C2-Py), 151.7 (s, C6-Py), 149.5 and 147.2 (both s, Cq), 137.4 
(s, CqN), 134.7 (s, C4-Py), 129.1, 128.4, 125.4, and 122.8 (all s, 
CHPh-IPr), 124.1 (s, C3-Py), 123.9 (s, =CHN), 120.5 (s, C5-Py), 
43.7 (d, JC-Rh = 16.6, CH2=CH2), 25.4 (s, CCH3-Py), 29.1 and 
28.9 (both s, CHMeIPr), 26.6, 26.1, 23.7, and 23.2 (all s, 
CHMeIPr). 
Preparation of RhCl(IPr)(2-coe)(4-picoline) (7). The 
complex was prepared as described for 3 starting for 1 (300 
mg, 0.236 mmol) and 4-picoline (230l, 2.329 mmol). Yield: 
280 mg (81%). Anal. Calcd. for C41H57N3ClRh: C, 67.43; H, 
7.87; N, 5.75. Found: C, 67.81; H, 7.98; N, 5.87. 
1
H NMR 
(300 MHz, tol-d8, 253 K): δ 8.22 (d, JH-H = 5.7, 2H, H2-Py), 
7.42-6.97 (m, 6H, HPh-IPr), 6.65 (s, 2H, =CHN), 6.08 (d, JH-H = 
5.7, 2H, H2-Py), 4.46 and 2.61 (both sept, JH-H = 6.3, 4H, 
CHMeIPr), 3.05 (m, 2H, CH=CHcoe), 1.75, 1.46, 1.14, and 1.03 
(all d, JH-H = 6.3, 24H, CHMeIPr), 1.7-0.8 (br, 12H, CH2-coe), 
1.50 (s, 3H, HCH3-Py). 
13
C{
1
H}-APT NMR plus HSQC and 
HMBC (75.6 MHz, tol-d8, 253 K):  185.8 (d, JC-Rh= 53.9, Rh-
CIPr), 153.0 (s, C2-Py), 149.1 and 146.1 (both s, Cq), 146.2 (s, 
C4-Py), 138.0 (s, CqN), 129.7, 128.5, 125.0, and 122.7 (all s, 
CHPh-IPr), 124.4 (s, =CHN), 123.5 (s, C3-Py), 55.4 (d, JC-Rh = 
16.5, CH=CHcoe), 30.3, 30.0, and 27.0 (all s, CH2-coe), 29.1 and 
 29.0 (both s, CHMeIPr), 26.8, 26.7, 24.1, and 22.8 (all s, 
CHMeIPr), 20.2 (s, CH3-Py). 
Preparation of RhCl(IPr)(2-CH2=CH2)(4-picoline) (8). 
The complex was prepared as described for 3 starting for 2 
(300 mg, 0.270 mmol) and 4-picoline (270l, 2.734 mmol). 
Yield: 277 mg (79%). Calcd. for C35H47N3ClRh: C, 64.86; H, 
7.31; N, 6.48. Found: C, 65.15; H, 7.45; N, 6.52. 
1
H NMR 
(400 MHz, C6D6, 298 K): δ 8.23 (d, JH-H = 6.0, 2H, H2-Py), 
7.34-7.00 (m, 6H, HPh-IPr), 6.60 (s, 2H, =CHN), 5.97 (d, JH-H = 
6.0, 2H, H3-Py), 4.11 and 3.14 (both br, 4H, CHMeIPr), 2.52 and 
2.12 (both br, 4H, CH2=CH2), 1.87-1.00 (br, 24H, CHMeIPr), 
1.50 (s, 3H, HCH3-Py). 
13
C{
1
H}-APT NMR plus HSQC and 
HMBC (100.6 MHz, C6D6, 298 K):  184.6 (d, JC-Rh= 53.7, 
Rh-CIPr), 151.8 (s, C2-Py), 147.4 and 147.2 (s, Cq), 146.8 (s, C4-
Py), 138.3 (s, CqN), 130.1 and 128.7 (all s, CHPh-IPr), 124.8 (s, 
=CHN), 124.7 (s, C3-Py), 42.1 (d, JC-Rh = 16.9, CH2=CH2), 29.6 
and 29.4 (both s, CHMeIPr), 26.8, 26.6, 24.1, 26.6 (both s, 
CHMeIPr), 20.5 (s, CCH3-Py). 
Preparation of RhCl(IPr)(2-coe)(2-ethylpyridine) (9). 
The complex was prepared as described for 3 starting for 1 
(300 mg, 0.236 mmol) and 2-ethylpyridine (270l, 2.36 
mmol). Yield: 285 mg (81%). Anal. Calcd. for C42H59N3ClRh: 
C, 67.78; H, 7.99; N, 5.65. Found: C, 68.19; H, 8.12; N, 5.82. 
1
H NMR (500 MHz, tol-d8, 253 K): δ 8.43 (d, JH-H = 5.3, 1H, 
H6-Py), 7.38-6.99 (m, 6H, HPh-IPr), 6.63 (dd, JH-H = 8.9, JH-H = 
7.8, 1H, H4-Py), 6.62 and 6.54 (both d, JH-H = 1.4, 2H, =CHN), 
6.39 (d, JH-H = 7.8, 1H, H3-Py), 6.20 (dd, JH-H = 8.9, JH-H = 5.3, 
1H, H5-Py), 4.93, 3.98, 3.11 and 2.90 (all sept, JH-H = 6.6, 4H, 
CHMeIPr), 3.65 and 3.34 (both dq, JH-H = 15.2, JH-H = 7.5, 2H, 
CH2-Py), 3.07 and 2.94 (both br, 2H, CH=CHcoe), 2.11, 2.02, 
1.59, 1.40, 1.29, 1.22, 1.08 and 0.92 (all d, JH-H = 6.6, 24H, 
CHMeIPr), 1.8-0.9 (br, 12H, CH2-coe), 1.03 (dd, JH-H = 7.5, JH-H 
= 7.5, 3H, CH3-Py). 
13
C{
1
H}-APT NMR plus HSQC and 
HMBC (125.6 MHz, tol-d8, 253 K):  184.7 (d, JC-Rh= 53.4, 
Rh-CIPr), 166.3 (s, C2-Py), 152.3 (s, C6-Py), 148.7, 148.6, 146.2, 
and 146.1 (all s, Cq), 137.9 and 137.2 (both s, CqN), 134.8 (s, 
C4-Py), 129.6, 129.4, 128.2, 125.6, 122.9, and 122.3 (all s, 
CHPh-IPr), 124.4 and 123.9 (both s, =CHN), 121.9 (s, C3-Py), 
119.6 (s, C5-Py), 58.3, 51.6 (both d, JC-Rh = 16.0, CH=CHcoe), 
32.9 (s, CH2-Py), 30.9, 30.4, 29.5, 29.4, 26.8, and 26.7 (all s, 
CH2-coe), 29.5, 29.2, 28.7 and 28.5 (all s, CHMeIPr), 27.5, 26.6, 
26.4, 26.2, 24.7, 23.5, 23.1 and 21.9 (all s, CHMeIPr), 13.4 (s, 
CH3-Py). 
Preparation of RhCl(IPr)(2-CH2=CH2)(2-ethylpiridine) 
(10). The complex was prepared as described for 3 starting for 
2 (300 mg, 0.270 mmol) and 2-ethylpyridine (310l, 2.71 
mmol). Yield: 315 mg (86%). Anal. Calcd. for C37H53N3ClRh: 
C, 65.53; H, 7.88; N, 6.20. Found: C, 65.89; H, 7.98; N, 6.33. 
1
H NMR (500 MHz, tol-d8, 253 K): δ 8.27 (d, JH-H = 5.1, 1H, 
H6-Py), 7.38-6.99 (m, 6H, HPh-IPr), 6.60 and 6.47 (both d, JH-H = 
1.5, 2H, =CHN), 6.57 (dd, JH-H = 9.0, JH-H = 7.7, 1H, H4-Py), 
6.27 (d, JH-H = 7.7, 1H, H3-Py), 6.09 (dd, JH-H = 9.0, JH-H = 5.1, 
1H, H5-Py), 4.42, 3.94, 3.15 and 2.45 (all sept, JH-H = 6.6, 4H, 
CHMeIPr), 3.60 and 3.06 (both dq, JH-H = 15.1, , JH-H = 7.6, 
2H, CH2-Py), 2.62, 2.31, 2.04 and 1.62 (all dd, JH-H = 11.7, JH-H 
= 8.4, 4H, CH2=CH2), 1.96, 1.6, 1.51, 1.36, 1.21, 1.13, 1.09 
and 1.01 (all d, JH-H = 6.6, 24H, CHMeIPr), 0.96 (dd, JH-H = 
7.6, JH-H = 7.6, 3H, CH3-Py). 
13
C{
1
H}-APT NMR plus HSQC 
and HMBC (125.6 MHz, tol-d8, 253 K):  184.3 (d, JC-Rh= 
53.8, Rh-CIPr), 165.5 (s, C2-Py), 151.6 (s, C6-Py), 148.7, 148.4, 
146.2, and 145.7 (all s, Cq), 137.6 and 137.2 (both s, CqN), 
135.0 (s, C4-Py), 129.8, 129.5, 128.2, 124.6, 123.0, and 122.6 
(all s, CHPh-IPr), 124.4 and 123.7 (both s, =CHN), 122.1 (s, C3-
Py), 120.9 (s, C5-Py), 44.5 and 36.9 (both d, JC-Rh = 17.3, 
CH2=CH2), 31.8 (s, CH2-Py), 29.4, 29.2, 28.8 and 28.6 (all s, 
CHMeIPr), 27.2, 26.6, 26.3, 26.1, 24.6, 23.3, 23.0 and 22.2 (all 
s, CHMeIPr), 13.6 (s, CH3-Py). 
In-situ preparation of RhClH(SPh)(IPr)(py) (11). A solu-
tion of 3 (23 mg, 0.032 mmol) in C6D6 (0.5 mL, NMR-tube) at 
20 ºC was treated with thiophenol (2.3 μL, 0.034 mmol). 
1
H 
NMR (500 MHz, C6D6, 293 K): δ 8.96 (d, JH-H = 5.0, 2H, H2-
Py), 7.42-6.88 (m, 11H, HPh), 6.85 (s, 2H, =CHN), 6.26 (d, JH-H 
= 7.6, 1H, H4-Py), 5.95 (dd, JH-H = 7.6-5.0, 2H, H3-Py), 3.76 and 
3.66 (both sept, JH-H = 6.3, 4H, CHMeIPr), 1.96, 1.53, 1.26 and 
1.10 (all d, JH-H = 6.3, 24H, CHMeIPr), –26.55 (d, JRh-H = 48.5, 
1H, Rh-H). 
In-situ preparation of RhClH(SPh)(IPr)(py)2 (11-py). A 
solution of 1 (22 mg, 0.017 mmol) in toluene-d8 (0.5 mL, 
NMR-tube) at -30 ºC was treated with pyridine (8 μL, 0.102 
mmol) and thiophenol (2.3 μL, 0.034 mmol). The 
1
H NMR 
was immediately recorded at low temperature. A mixture of 11 
and 11-py were observed in 1:2.5 ratio (at 293 K). Data for 
11-py: 
1
H NMR (500 MHz, tol-d8, 243 K): δ 9.58 and 9.31 
(both br, 2H, Ho-Py-A), 9.06 (br, 2H, Ho-Py-B), 7.40-6.40 (br, 
11H, HPh and  =CHN), 6.62 (br, 1H, Hp-Py-A), 6.24 (br, 1H, Hp-
Py-B), 6.51 and 6.07 (both br, 2H, Hm-Py-A), 6.06 (br, 2H, Hm-Py-
B), 4.37, 4.02, 3.51 and 3.26 (all br, 4H, CHMeIPr), 2.21, 1.67, 
1.65, 1.60, 1.33, 1.22, 1.17 and 1.04 (all br, 24H, CHMeIPr), –
16.27 (d, JRh-H = 15.4, 1H, Rh-H).  
In-situ preparation of RhClH(SCH2Ph)(IPr)(py)2 (12-py). 
A solution of 1 (22 mg, 0.017 mmol) in toluene-d8 (0.5 mL, 
NMR-tube) at -30 ºC was treated with pyridine (8 μL, 0.102 
mmol) and benzylthiol (3.6 μL, 0.034 mmol). The 
1
H NMR 
was immediately recorded at low temperature. 
1
H NMR (500 
MHz, tol-d8, 223 K): δ 9.49 and 9.20 (both d, JH-H = 4.9, 2H, 
Ho-Py--A), 9.44 (d, JH-H = 5.2, 2H, Ho-Py--B), 7.40-6.90 (m, 11H, 
HPh), 6.72 and 6.49 (both br, 2H, =CHN), 6.61 (br, 1H, Hp-Py-
A), 6.43 (br, 1H, Hp-Py-B), 6.42 and 5.96 (both br, 2H, Hm-Py-A), 
6.24 (br, 2H, Hm-Py-B), 4.56, 3.97, 3.55 and 2.85 (all sept, JH-H 
= 6.2, 4H, CHMeIPr), 2.45 and 2.20 (both d, JH-H = 11.7, 2H, 
CH2S), 2.06, 1.87, 1.71, 1.34, 1.32, 1.22, 1.16 and 0.93 (all d, 
JH-H = 6.2, 24H, CHMeIPr), –17.10 (d, JRh-H = 15.2, 1H, Rh-H). 
In-situ preparation of RhClH(SCH2Ph)(IPr)(2-Etpy) 
(13). A solution 10 (19 mg, 0.026 mmol) in toluene-d8 (0.5 
mL, NMR-tube) at -50 ºC was treated with benzylthiol (3 μL, 
0.028 mmol). The 
1
H NMR was immediately recorded at low 
temperature. 
1
H NMR (500 MHz, tol-d8, 223 K): δ 7.68 (d, JH-
H = 5.0, 1H, H6-Py), 7.40-7.00 (m, 11H, HPh), 6.60 (dd, JH-H = 
8.7, JH-H = 7.6, 1H, H4-Py), 6.59 and 6.56 (both br, 2H, =CHN), 
6.20 (d, JH-H = 7.6, 1H, H3-Py), 6.02 (dd, JH-H = 8.7, JH-H = 5.0, 
1H, H5-Py), 3.82, 3.80, 3.50 and 3.31 (all sept, JH-H = 6.2, 4H, 
CHMeIPr), 2.48-2.42 (m, 2H, CH2-Py), 2.78 and 2.49 (both d, 
JH-H = 12.5, 2H, CH2S), 1.78, 1.73, 1.69, 1.58, 1.22, 1.17, 1.15 
and 1.06 (all d, JH-H = 6.2, 24H, CHMeIPr), 0.89 (dd, JH-H = 
7.5-7.3, 3H, CH3-Py), –26.93 (d, JRh-H = 47.0, 1H, Rh-H). 
Preparation of S-(phenylvinyl)-N-Boc-L-cysteine-
methylester. A Schelnk tube containing 1 ml of toluene was 
charged with 11.1 mg (0.01 mmol) of catalyst 2, 16 μL of 
pyridine (15.6 mg, 0.2 mmol), 200μL (229 mg, 1 mmol) of N-
(tert-butoxycarbonyl)-L-cysteine methyl ester and 110 μL (102 
mg, 1 mmol) of phenylacetylene were added. The yellow 
 solution was stirred for 30 minutes at r.t. and then filtered 
through silica gel, in order to remove the catalyst. Finally the 
solution was concentrated under vacuum and analyzed by 
NMR. The conversion was complete and a ratio of 90/10 of 
branched/linear hydrothiolation product was obtained. S-(1-
phenylvinyl)-N-Boc-L-cysteine-methylester:
 1
H NMR (500 
MHz, C6D6, 298 K): δ 7.58 (d, JH-H = 6.8, 2H, Ho-Ph), 7.23-
7.18 (m, 3H, Hm+p-Ph), 5.70 (d, JH-H = 8.4, 1H, NH),  5.44 and 
5.38 (both s, 2H, =CH2), 4.79 (dt, JH-H = 8.4 JH-H = 4.9, 1H, 
NCH), 3.34 (s, 3H, OCH3), 3.14 and 2.97 (dd, JH-H = 13.7, JH-
H = 4.9, 2H, SCH2), 1.49 (s, 9H, CH3-tBu). 
13
C{
1
H} APT NMR 
plus HSQC and HMBC (125.6 MHz, C6D6, 298 K):  171.0 
(s, C-C=O), 155.1 (s, N-C=O), 144.1 (s, C=CH2), 139.3 (s, Cq-
Ph), 128.5 (s, Cp-Ph), 128.4 (s, Cm-Ph), 127.5 (s, Co-Ph), 113.3 (s, 
=CH2), 79.4 (s, Cq-tBu), 53.2 (s, N-CH), 51.7 (s, O-CH3), 34.3 
(s, S-CH2), 28.1 (s, CH3-tBu). S-(2-phenylvinyl)-N-Boc-L-
cysteine-methylester. 
1
H NMR (500 MHz, C6D6, 298 K): δ  
7.61 (d, JH-H = 6.9, 2H, Ho-Ph), 7.25-7.15 (m, 3H, Hm+p-Ph), 6.65 
(d, JH-H = 15.6, 1H, S-CH=), 6.59 (d, JH-H = 15.6, 1H, =HC-
Ph), 5.73 (d, JH-H = 8.0, 1H, NH), 4.81 (dt, JH-H = 8.0-4.8, 1H, 
N-CH), 3.38 (s, 3H, O-CH3), 3.23 and 3.11 (dd, JH-H = 14.1-
4.8, 2H, S-CH2), 1.47 (s, 9H, CH3-tBu). 
13
C{
1
H} APT NMR 
plus HSQC and HMBC (125.6 MHz, C6D6, 298 K): 170.8 
(s, C-C=O), 155.0 (s, N-C=O), 136.9 (s, Cq-Ph), 129.1 (Ph-
CH=CH), 128.6 (s, Cm-Ph), 127.1 (s, Cp-Ph), 125.8 (s, Co-Ph), 
121.6 (s, C=CH-S), 79.5 (s, Cq-tBu), 53.8 (s, N-CH), 51.9 (s, O-
CH3), 35.4 (s, S-CH2), 28.0(s, CH3-tBu). 
Preparation of Phenyl(1-(4-
(trifluoromethyl)phenyl)vinyl)sulfane.The product was 
prepared as descrive for S-(phenylvinyl)-N-Boc-L-cysteine-
methylester starting for 1-ethynyl-4-(trifluoromethyl)benzene 
(158 L, 1 mmol). The reaction time was 4h, the conversion 
was complete and a ratio of 97/3 of branched/linear hy-
drothiolation product was obtained.
 1
H NMR (500 MHz, C6D6, 
298 K):  7.53 (d, JH-H = 8.1, 2H, H2-Ph-CF3), 7.38 (m, 2H, Ho-Ph-
S), 7.33 (d, JH-H = 8.1, 2H, H3-Ph-CF3), 7.05 (m, 2H, Hm-Ph-S), 
6.99 (m, 1H, Hp-Ph-S), 5.51 and 5.39 (both s, C=CH2). 
13
C{
1
H} 
APT NMR plus HSQC and HMBC (125.6 MHz, C6D6, 298 
K):  143.6 (s, C=CH2), 142.3 (s, C1-Ph-CF3), 133.3 (s, Cq-Ph-S), 
132.0 (s, Co-Ph-S), 130.2 (q, JC-F = 32.4, C4-Ph-CF3), 129.2 (s, Cm-
Ph-S), 127.6 (s, C2-Ph-CF3), 127.5 (s, Cp-Ph-S), 125.3 (q, JC-F = 3.8, 
C3-Ph-CF3), 124.5 (q, JC-F = 272.6, CF3), 117.61 (s, C=CH2).
 19
F 
NMR (470 MHz, C6D6, 298K):  -62.39 (s, CF3). 
Preparation of 1,6-bis((1-phenylvinyl)thio)hexane. The 
product was prepared as described for S-(phenylvinyl)-N-Boc-
L-cysteine-methylester starting for 1,6-hexanedithiol (40 L, 
0.5 mmol) with a molar ratio 1,6-
hexanedithiol:phenylacetilene = 1:2. The reaction time was 0,7 
h, the conversion was complete and a ratio of 88/12 of 
branched-branched/branched-linear hydrothiolation product 
was obtained. 1,6-bis((1-phenylvinyl)thio)hexane: 
1
H NMR 
(300 MHz, C6D6, 298 K):  7.72 (dd, JH-H = 8.1, JH-H = 1.2, 
4H, Ho-Ph), 7.3-7.1 (br, 6H, Hm+p-Ph), 5.51 and 5.24 (both s, 4H, 
C=CH2), 2.54, 1,50 and 1,17 (br, 12H, CH2-alkylic). 
13
C{
1
H} 
APT NMR plus HSQC and HMBC (75.4 MHz, C6D6, 298 K): 
 145.8 (s C=CH2), 140.1 (s, Cq-Ph), 128.4 (s, Cm-Ph), 128.3 (s, 
Cp-Ph), 127.3 (s, Co-Ph), 110.3 (s, C=CH2), 31.9, 28.4 and 28.3 
(all s, CH2-Alkylic). 
Standard catalytic conditions. In a NMR tube 0.01 equiva-
lent of catalyst were dissolved in 0.5 mL of C6D6 and then 0.5 
mmol of thiol and 0.5 mmol of alkyne were added. The alkyne 
conversion to vinyl sulfide and the conversion was quantified 
by integration of the 
1
H-NMR spectrum. Reaction product 
formation was also monitored at periodic time intervals by 
using GC-MS analyses. 
Molecular Structure Determination for complexes 2 and 
3. Single crystals for the X-ray diffraction study of 2 and 3 
were grown by slow diffusion of n-hexane into a saturated 
solution of the complexes in toluene. Intensity data for both 
complexes were collected at low temperature (100(2)K) on a 
Bruker SMART CCD area detector diffractometer equipped 
with graphite monochromated Mo-K radiation ( = 0.71073 
Å) using narrow frames (0.3˚ in ). Data were corrected for 
Lorentz and polarization effects, and a semiempirical absorp-
tion correction was applied using SADABS program.
49
 The 
structures were solved by Patterson method and completed by 
successive difference Fourier syntheses. Refinements were 
carried out by full-matrix least-squares on F
2
 with SHELXL-
97,
50
 including isotropic and subsequent anisotropic displace-
ment parameters for all non-hydrogen atoms. Hydrogen atoms 
for the ethylene molecules in 2 were obtained from difference 
Fourier maps and refined as free isotropic atoms; the rest of 
hydrogens were included in calculated positions and refined as 
riding atoms. In the case of 3, two regions of disorder were 
observed and modeled with two moieties with complementary 
occupancy factors. Only two residual peaks above 1.00 e
-
/Å
3
 
were observed in 3, but were located in close proximity of the 
rhodium atoms. 
Crystal data for 2: C58H80Cl2N4Rh2, M = 1109.98, triclinic, 
space group P 1 , orange crystal 0.191 x 0.186 x 0.154 mm, a 
= 10.2222(4), b = 12.2208(5), c = 13.5228(5) Å, α = 
101.2870(5), β = 110.5192(5), γ = 111.5633(4)°, V = 
1365.44(9) Å
3
, Z = 1, μ(MoKα) = 0.742 mm
-1
, Dcalc = 1.35 g 
cm
-3
, min & max. trans. factors 0.804 and 0.907. 16152 reflec-
tions measured (1.73 ≤  ≤ 30.52º, sen ≤ 0.715 Å-1), 7570 
independent reflections (Rint = 0.0161); number of da-
ta/restrains/parameters 7570/0/322. The final R1 and wR(F
2
) 
values were 0.0216 and 0.0553 for I > 2σ(I), and 0.0227 and 
0.0560 for all data, respectively; S = 1.035 for all data. 
Crystal data for 3: C40H55ClN3Rh, M = 716.26, triclinic, 
space group P 1 , yellow crystal 0.213 x 0.161 x 0.057 mm, a 
= 10.374(3), b = 10.874(3), c = 17.559(4) Å, α = 85.301(3), β 
= 75.467(3), γ = 72.538(3)°, V = 1829.1(8) Å
3
, Z = 2, 
μ(MoKα) = 0.571 mm
-1
, Dcalc = 1.301 g cm
-3
, min & max. 
absorp. correc. factors 0.813 and 1.139. 18989 reflections 
measured (1.96 ≤  ≤ 26.37º, sen ≤ 0.625 Å-1), 7439 inde-
pendent reflections (Rint = 0.0667); number of da-
ta/restrains/parameters 7439/6/455. The final R1 and wR(F
2
) 
values were 0.0570 and 0.1263 for I > 2σ(I), and 0.0893 and 
0.1372 for all data, respectively. The goodness of fit on F
2
 was 
1.006. 
Computational Details. All the calculations have been per-
formed with the Gaussian09 package
51
 at the B3LYP level.
52
 
The rhodium atom was were represented by the relativistic 
effective core potential (RECP) from the Stuttgart group and 
the associated basis set.
53
 The remaining atoms (C, H, N, O, 
Cl, S) were represented by a 6-31G(d) basis set. Full optimiza-
tions of geometry without any constraint were performed, 
followed by analytical computation of the Hessian matrix to 
 confirm the nature of the stationary points as minima or transi-
tion structure on the potential energy surface. 
Determination of rotational barriers. Full line-shape anal-
ysis of the dynamic 
1
H NMR spectra of 2, 3, 4 and 6 were 
carried out using the program gNMR (Cherwell Scientific 
Publishing Limited). The transverse relaxation time, T2, was 
estimated at the lowest temperature. Activation parameters 
H

 and S

 were obtained by linear least-squares fit of the 
Eyring plot. Errors were computed by published methods.
48
 
ASSOCIATED CONTENT  
Crystalographic data and processing parameters for compounds 2 
and 3, determination of thermodynamic parameters of the equilib-
rium between 6 and 2, cartesian coordinate for theoretical calcu-
lated compounds, and complete Reference 51. This material is 
available free of charge via the Internet at http://pubs.acs.org.  
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